Loading CV, please wait...

CURRICULUM VITAE

DR. CHAN WAH LOONG
DR. CHAN WAH LOONG
Medical Lecturer
Department of Medicine
Faculty of Medicine
0163774573
ResearcherID
Scopus Author ID
ORCID ID
Google Scholar

BIOGRAPHY

Dr. Chan Wah Loong received his M.D. certificate in 2014 from Universiti Sains Malaysia and has completed his specialty training in internal Medicine at University of Malaya. He has earned distinction in the final part of his MMed Master in Internal Medicine training.

He was the Head Of Department and Internal Medicine Specialist in Hospital Keningau from 2023-2024. He was also the Head of Antimicrobial Stewardship and specialist in charge of Infectious Control Unit for Kluster Keningau, Sabah.

He is currently a trainee in Gastroenterology and Hepatology under Faculty of Medicine, University of Malaya.

He is a passionate doctor who has a strong interest in research, publications, and journalism involving topics in various subspecialties of internal medicine especially Gastroenterology and Hepatology. He is the winner for the First Prize in Young Investigator Awards and Third Prize in Best Poster Awards in GUT 2025 (Malaysian Society of Gastroenterology and Hepatology Annual Scientific Meeting).

ACADEMIC QUALIFICATION

  • MASTER OF INTERNAL MEDICINE, (INTERNAL MEDICINE)
    Universiti Malaya (UM)
  • MD, (MEDICINE)
    Universiti Sains Malaysia (USM)

ADMINISTRATIVE DUTIES

  • PENYELARAS PROGRAM (SEKRETARIAT TETAP PROGRAM TRAINING OF TRAINERS (ToT) NATIONAL POSTGRADUATE MEDICAL CURRICULUM (NPMC) BAGI TAHUN 2025 – 2027)
    01 Jun 2025 - 31 May 2028 (National)
  • Coordinator
    02 Jan 2025 - 31 Dec 2027 (Department)
  • Coordinator for the task force in Internal Medicine.
    20 Oct 2026 - 22 Oct 2026 (National)
  • Case finder and coordinator for task force in organizing Clinical Part II (Old system) during May 2026
    05 May 2026 - 06 May 2026 (National)
  • Case finder and coordinator for task force in organizing Clinical Part II during May 2026
    05 May 2026 - 06 May 2026 (National)

MEMBERSHIPS

  • EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER (EASL), MEMBER
    2026 to present (International)
  • MALAYSIAN SOCIETY OF GASTROENTEROLOGY & HEPATOLOGY (MSGH), MEMBER
    2026 to present (National)
  • MALAYSIAN MEDICAL ASSOCIATION (MMA), MEMBER
    Since 2016 (National)
  • MALAYSIAN SOCIETY OF GASTROENTEROLOGY & HEPATOLOGY, MEMBER
    2024 to 2025 (National)

AWARD AND STEWARDSHIP

  • AOCC 2026 & IMKASID 2026 International Travel Grant Award
    2026, Asian Organization for Crohns & Colitis AOCC and Korean Association for the Study of Intestinal Diseases,  (International)
  • GUT 2025 - BEST POSTER AWARD (THIRD PRIZE)
    2025, MALAYSIAN SOCIETY OF GASTROENTEROLOGY AND HEPATOLOGY,  (National)
  • GUT 2025 YOUNG INVESTIGATOR AWARD - FIRST PRIZE
    2025, MALAYSIAN SOCIETY OF GASTROENTEROLOGY AND HEPATOLOGY,  (National)

PUBLICATIONS

Article in Journal
WoS
  1. Chuah, KH; Loo, QY; Loh, AJC; Leong, JY; Chan, WL; Khoo, XH; Wong, KL; Panirsheeluam, S; Natarajan, V; Ng, A; Majid, HA; Mahadeva, S (2026). Clinical Trial: Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. . doi:10.1111/apt.70420
  2. Chuah, KH; Loo, QY; Loh, AJC; Leong, JY; Chan, WL; Khoo, XH; Wong, KL; Panirsheeluam, S; Natarajan, V; Ng, A; Majid, HA; Mahadeva, S (2026). Letter: Rifaximin Versus Low FODMAP Diet in IBS: What the Primary Endpoint Does Not Tell Us. Authors' Reply, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. . doi:10.1111/apt.70553
  3. Chuah, KH; Loo, QY; Loh, AJC; Leong, JY; Chan, WL; Khoo, XH; Wong, KL; Panirsheeluam, S; Natarajan, V; Ng, AK; Majid, HA; Mahadeva, S (2026). Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome-It Is Nice to Have a Choice. Authors' Reply, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. . doi:10.1111/apt.70469
  4. Chan, Wah Loong; Chee, Nicholas Ming-Zher; Lai, Lee-Lee; Chuah, Kee Huat; Mahadeva, Sanjiv; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Chan, Wah Kheong (2024). A Post-hoc Analysis : Association Between Metabolic Dysfunction-Associated Fatty Liver Disease Subgroups and Long-term Outcomes, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39, 488-488
  5. Chan, Wah Loong; Chuah, Kee Huat (2024). Editorial: The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease, ALIMENTARY PHARMACOLOGY & THERAPEUTICS. . doi:10.1111/apt.18304
  6. Chan, Wah Loong; Chuah, Kee Huat; Loo, Qing Yuan; Loh, Audrey Joe Chii; Hian, Wen Xuan; Khoo, Xin Hui; Panirsheeluam, Sarala; Majid, Hazreen Abdul; Mahadeva, Sanjiv (2024). Rifaximin Therapy Versus Low FODMAP Diet in Irritable Bowel Syndrome: A Randomised Controlled Trial, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39, 337-337
  7. Chan, Wah Loong; Khamis, Farahani; Ahmad, Khairiah; Khoo, Stanley (2024). Paradigm shift: Case report of synergistic use of eus-guided gastrojejunostomy (EUS-GJ) and Hepaticogastrostomy(EUS-HGS) for malignant obstruction, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39, 216-216
  8. Chan, Wah Loong; Tan, Yee Ling; Chuah, Kee Huat; Khoo, Stanley; Chan, Wah Kheong (2024). Ancient Remedies, Modern Risks: Case Series of Acute Liver Failure Due to Traditional Complementary Medicine, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39, 383-383
  9. Chan, Wah Loong; Xaviar, Sivaraj; Nyipa, Esther Jara Edmund; Khoo, Stanley (2024). Case Report: AI-Assisted Capsule Endoscopy Rapidly Detecting Obscure Gastrointestinal Bleeding in High-Risk Cardiac Patients, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39, 416-416
  10. Leow, Yong Wen; Chan, Wah Loong; Lai, Lee Lee; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Quiambao, Ronald; Munteanu, Mona; Chan, Wah Kheong (2024). LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 39(10), 2182-2189. doi:10.1111/jgh.16675
  11. Chan, Wah Loong; Chong, Shi-En; Chang, Felicia; Chuah, Kee Huat; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Chan, Wah-Kheong (2023). Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy, HEPATOLOGY INTERNATIONAL. . doi:10.1007/s12072-023-10550-9
  12. Chan, Wah Loong; Chong, Shi-En; Chang, Felicia; Chuah, Kee Huat; Mustapha, Nik Raihan Nik; Mahadeva, Sanjiv; Chan, Wah-Kheong (2023). The use of non-invasive tests compared with histological fibrosis stage in predicting liver-related events in metabolic dysfunction-associated fatty liver disease, JOURNAL OF HEPATOLOGY. 78, S710-S711
  13. Chan, Wah Loong; Kumar, C. Vikneshwaran Chandra; Chan, Wah Kheong (2023). Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis, HEPATOBILIARY SURGERY AND NUTRITION. 12(5), 763-767. doi:10.21037/hbsn-23-346
Scopus
  1. Chuah K.H., Loo Q.Y., Loh A.J.C., Leong J.Y., Chan W.L., Khoo X.H., Wong K.L., Panirsheeluam S., Natarajan V., Ng A.K., Abdul Majid H., Mahadeva S. (2026). Clinical Trial: Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome, Alimentary Pharmacology and Therapeutics. . doi:10.1111/apt.70420
  2. Chuah K.H., Loo Q.Y., Loh A.J.C., Leong J.Y., Chan W.L., Khoo X.H., Wong K.L., Panirsheeluam S., Natarajan V., Ng A.K., Abdul Majid H., Mahadeva S. (2026). Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome It Is Nice to Have a Choice. Authors' Reply, Alimentary Pharmacology and Therapeutics. . doi:10.1111/apt.70469
  3. Leow Y.W., Chan W.L., Lai L.L., Mustapha N.R.N., Mahadeva S., Quiambao R., Munteanu M., Chan W.K. (2024). LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease, Journal of Gastroenterology and Hepatology (Australia). . doi:10.1111/jgh.16675

RESEARCH PROJECT

Private
  1. 2023 - 2029, JANSSEN RESEARCH & DEVELOPMENT, LLC
    A PHASE 2B RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 48-WEEKS COMBINATION THERAPY WITH GUSELKUMAB AND GOLIMUMAB IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE CROHN S DISEASE (DUET-CD) ( Co-Researcher)
  2. 2025 - 2027, ASTRAZENECA SDN. BHD.
    A DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AZD7798 IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE (AMALTHEA) ( Co-Researcher)
  3. 2024 - 2027, JANSSEN RESEARCH & DEVELOPMENT, LLC
    A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO DEMONSTRATE THE EFFICACY AND SAFETY OF MILVEXIAN, AN ORAL FACTOR XIA INHIBITOR, AFTER A RECENT ACUTE CORONARY SYNDROME ( Co-Researcher)
  4. 2024 - 2025, ABOTT HEALTHCARE PRODUCTS B.V
    A RANDOMIZED, MULTICENTRE, PARALLEL GROUP, OPEN-LABEL, ACTIVE-CONTROLLED STUDY TO INVESTIGATE THE NON-INFERIORITY OF ITOPRIDE HYDROCHLORIDE 150MG EXTENDED RELEASE TABLETS ONCE DAILY VERSUS ITOPRIDE HYDROCHLORIDE 50 MG FILM COATED TABLETS THRICE DAILY IN SUBJECTS WITH GASTROINTESTINAL SYMPTOMS CAUSED BY GASTRIC DYSMOTILITY AND DELAYED GASTRIC EMPTYING LIKE BLOATING SENSATION, EARLY SATIETY, POSTPRANDIAL FULLNESS, UPPER ABDOMINAL PAIN OR DISCOMFORT, ANOREXIA, HEARTBURN, NAUSEA, AND VOMITING IN FUNCTIONAL (NON-ULCER) DYSPEPSIA OR CHRONIC GASTRITIS ( Co-Researcher)
International
  1. 2024 - 2028, GILEAD SCIENCES, INC.
    A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, 2-PART PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GS-1427 IN ADULT PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC)PART 1: PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF GS-1427; PART 2: ACTIVE-CONTROLLED, COMBINATION STUDY EVALUATING THE EFFICACY AND SAFETY OF GS-1427 IN COMBINATION WITH USTEKINUMAB VERSUS GS-1427 OR USTEKINUMAB MONOTHERAPY ( Co-Researcher)

PAPER PRESENTED

Invited Speaker
  1. Beyond Drink More Water and Eat More Fibre : Diet, Fibre & Non-Pharmacological Measures in Chronic Constipation, NeuroGut 2026 Singapore's Premier Scientific Meeting on Neurogastroenterology, Gastrointestinal Motility and Disorders of Gut Brain Interaction, NeuroGut 2026 Organising Committee, Singapore (International) (18 Jul 2026 - 19 Jul 2026)
Oral Presenter
  1. DELIVERING HEPATITIS C CURE BEYOND SPECIALIST CENTRES: A REGISTRY-BASED REAL-WORLD STUDY OF DECENTRALISED SOFOSBUVIR-RAVIDASVIR THERAPY IN MALAYSIA, GUT 2026 Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology, Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (28 Aug 2026 - 30 Aug 2026)
  2. Paradigm Shift: Case Report of Synergistic Use of EUS-Guided Gastrojejunostomy(EUS-GJ) and Hepaticogastrostomy(EUS-HGS) for Malignant Obstruction, Asian Pacific Digestive Week 2024, The Asian Pacific Digestive Week Federation (APDWF) (International) (21 Nov 2024 - 24 Nov 2024)
Poster Presenter
  1. Diagnostic Spectrum and Referral Patterns for High-Resolution Esophageal Manometry at a Malaysian Tertiary Centre, GUT 2026 Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology, Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (28 Aug 2026 - 30 Aug 2026)
  2. Clinical Heterogeneity and Severe Complications of Cronkhite-Canada Syndrome: A Malaysian Tertiary-Centre Case Series, GUT 2026 Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology, Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (28 Aug 2026 - 30 Aug 2026)
  3. Clinical Outcomes After Colonic Self-Expandable Metal Stenting: Treatment-Pathway Completion, Survival and Stoma Avoidance, GUT 2026 Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology, Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (28 Aug 2026 - 30 Aug 2026)
  4. Clinical Burden and Treatment Satisfaction in Primary Chronic Constipation: A Malaysian Tertiary-Care Study, GUT 2026 Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology, Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (28 Aug 2026 - 30 Aug 2026)
  5. Predictors of Early Clinical Failure After Colonic Self-Expandable Metal Stenting for Large-Bowel Obstruction, GUT 2026 Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology, Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (28 Aug 2026 - 30 Aug 2026)
  6. Cronkhite-Canada Syndrome: A Case Series of Diverse Outcomes from Complete Remission to Life-Threatening Complications at a Malaysian Tertiary Centre, AOCC 2026 & IMKASID 2026 The 14th Annual Meeting of the Asian Organization for Crohn's & Colitis in conjunction with the 9th International Meeting on Intestinal Diseases and Annual Congress of the Korean Association for the Study of Intestinal Diseases, Asian Organization for Crohn's & Colitis (AOCC) and Korean Association for the Study of Intestinal Diseases (KASID) (International) (25 Jun 2026 - 27 Jun 2026)
  7. Achalasia in Adolescents: A Case Series Highlighting Improvement with Peroral Endoscopic Myotomy (POEM), ASIAN PACIFIC DIGESTIVE WEEK (APDW) 2025 SINGAPORE, APDW 2025 (International) (20 Nov 2025 - 22 Nov 2025)
  8. Frequency, predictive factors, and burden of gastrointestinal symptoms in Asian Patients with Type 2 Diabetes, Asian Pacific DIgestive Week (APDW) 2025 Singapore, APDW 2025 Singapore (International) (20 Nov 2025 - 22 Nov 2025)
  9. Achalasia in Adolescents: A Case Series Highlighting Diagnostic Challenges and Symptom Resolution with Peroral Endoscopic Myotomy (POEM), GUT 2025 (Annual Scientific Meeting of MSGH), Malaysian Society of Gastroenterology & Hepatology (MSGH) (National) (08 Aug 2025 - 10 Aug 2025)
  10. Case Report: AI-Assisted Capsule Endoscopy Rapidly Detecting Obscure Gastrointestinal Bleeding in High-Risk Cardiac Patients, Asian Pacific Digestive Week 2024, The Asian Pacific Digestive Week Federation (APDWF) (International) (21 Nov 2024 - 24 Nov 2024)
  11. Ancient Remedies, Modern Risks: Case Series of Acute Liver Failure Due to Traditional Complementary Medicine, Asian Pacific Digestive Week 2024, The Asian Pacific Digestive Week Federation (APDWF) (International) (21 Nov 2024 - 24 Nov 2024)
  12. Rifaximin Therapy Versus Low FODMAP Diet in Irritable Bowel Syndrome: A Randomised Controlled Trial, Asian Pacific Digestive Week 2024, The Asian Pacific Digestive Week Federation (APDWF) (International) (21 Nov 2024 - 24 Nov 2024)
  13. A Post-hoc Analysis : Association Between Metabolic Dysfunction-Associated Fatty Liver Disease Subgroups and Long-term Outcomes, Asian Pacific Digestive Week 2024, The Asian Pacific Digestive Week Federation (APDWF) (International) (21 Nov 2024 - 24 Nov 2024)
  14. A Randomised Controlled Trial Of Rifaximin Therapy Versus Low FODMAP Diet In Irritable Bowel Syndrome: An Interim Analysis, Annual Scientific Meeting of MSGH: GUT 2024, Malaysian Society of Gastroenterology & Hepatology (National) (16 Aug 2024 - 18 Aug 2024)
  15. A Paradigm Shift in Management of Complex Malignant Obstruction: Synergistic Application of Endoscopic ultrasound guided gastrojejunostomy (EUS-GJ) and Endoscopic ultrasound guided hepaticogastrostomy, Annual Scientific Meeting of MSGH: GUT 2024, Malaysian Society of Gastroenterology & Hepatology (National) (16 Aug 2024 - 18 Aug 2024)
  16. Diagnosis of Obscure GI Bleeding in a High-Risk Cardiac Patient: Real-World Experience with AI-Assisted Capsule Endoscopy, Annual Scientific Meeting of MSGH: GUT 2024, Malaysian Society of Gastroenterology & Hepatology (National) (16 Aug 2024 - 18 Aug 2024)

ACADEMIC/ PROF. SERVICES

Evaluation
  1. (2026) External Examiner for Internal Medicine Qualifying Assessment (imqa) Program Sarjana Perubatan (perubatan Dalaman) Sesi Mei 2026 @ IIUM, National, (External Examiner)
  2. (2025) External Examiner for Clinical Exam of Internal Medicine Qualifying Assessment (imqa) in UiTM, National, (External Examiner)
  3. (2025) Expert Panelist for Standard Setting Imqa (internal Medicine Quality Assessment), National, (External Examiner)
  4. (2025) UM Representative for May 2025 Standard Setting for Imqa (internal Medicine Qualifying Assessment) Exam, National, (External Examiner)
Contribution to Event
  1. (2025) Organizing Committee for Masterclass in Medicine 2025, University, (Course Facilitator)
  2. (2025) Speaker On Crucial Nursing Skills and Knowledge in Gi Resuscitation: Enhancing Patient Outcomes, National, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
  1. (2026) RETROSPECTIVE EVALUATION OF DIAGNOSTIC YIELD AND SAMPLE ADEQUACY OF EUS GUIDED FNA/FNB FOR GASTROINTESTINAL AND HEPATOPANCREATOBILIARY LESIONS IN A MALAYSIA TERTIARY CENTRE, CHEW HAN JIA
  2. (2026) DOES THE VOLUME OF SPUTUM COLLECTION AFFECT THE SENSITIVITY OF TUBERCULOSIS (TB) DIAGNOSIS, FATHEEN ATHEERAH BINTI ABDUL R ABDUL RASHID
  3. (2026) CLINICAL OUTCOMES FOLLOWING COLONIC STENTING FOR LARGE BOWEL OBSTRUCTION IN A TERTIARY MEDICAL CENTRE: A RETROSPECTIVE COHORT STUDY, TINA PREET KAUR DHARSHAN SINGH

COURSE ATTENDED

Internal/ External Course
  1. NEUROGUT 2026, PARADOX SINGAPORE (18 Jul 2026 - 20 Jul 2026)
  2. NATIONAL GASTROENTEROLOGY AND HEPATOLOGY TRAINING BOARD "GI PATHOLOGY DAY", BILIK SEMINAR, HOSPITAL SULTAN ABDUL AZIZ SHAH (HSAAS), UPM (08 May 2026 - 08 May 2026)
  3. PANCREAS SUMMIT 2026: ASEAN REGIONAL SCIENTIFIC MEETING IN COLLABORATION WITH GI-TAP SOCIETY, JEN PENANG GEORGETOWN BY SHANGRI-LA (10 Apr 2026 - 11 Apr 2026)
  4. NATIONAL HEPATOLOGY TRAINING DAY & PRECEPTORSHIP, HOSPITAL AMPANG HOSPITAL SELAYANG PUSAT PERUBATAN UNIVERSITI MALAYA (08 Feb 2026 - 11 Feb 2026)
  5. MOTILITY EXPERT DEVELOPMENT PROGRAMME : NEUROGASTROENTEROLOGY AND MOTILITY CONSTIPATION FOCUS, RITZ CARLTON HOTEL MEGA KUNINGAN, JAKARTA, INDONESIA, MUTIARA BALLROOM 2, LG FLOOR (09 Jan 2026 - 11 Jan 2026)
  6. ASIAN PACIFIC DIGESTIVE WEEK (APDW) 2025, SUNTEC, SINGAPORE (17 Nov 2025 - 22 Nov 2025)
  7. FACILITATING SKILLS LEARNING IN COMPETENCY 29-30 JULY 2025, CUBE, ARAS 4, BLOK M, FAKULTI PERUBATAN, UNIVERSITI MALAYA (29 Jul 2025 - 30 Jul 2025)
  8. KURSUS 'NATIONAL HEPATOLOGY -GI MASTERCLASS 1.2' UNTUK PELATIH SUBKEPAKARAN HEPATOLOGI & GASTROENTEROLOGI, BILIK SEMINAR 1, INSTITUT ENDOKRIN, HOSPITAL PUTRAJAYA (14 Jul 2025 - 15 Jul 2025)
  9. 6TH SCIENTIFIC MEETING OF THE SOUTH EAST ASIA GASTRO-NEURO MOTILITY ASSOCIATION, AC HOTEL BY MARRIOTT IPOH, MALAYSIA (11 Jul 2025 - 13 Jul 2025)
  10. ADVANCED WORKSHOP FOR EARLY CAREER RESEARCHERS (ECR), WYNDHAM GRAND BANGSAR, KUALA LUMPUR (21 Apr 2025 - 21 Apr 2025)
  11. ADVANCING SCHOLARS IN CAREER DEVELOPMENT AND EDUCATION (ASCEND) S2/2025, BILIK SENAT, UNIVERSITI MALAYA (07 Apr 2025 - 18 Apr 2025)
  12. OSCE/OSPE FOR ASSESSMENT OF HEALTH PROFESSIONALS, CUBE, ARAS 4, FAKULTI PERUBATAN., UM (05 Mar 2025 - 05 Mar 2025)
  13. FOUNDATIONS OF ASSESSMENT FOR HEALTH PROFESSIONALS 4 MAC 2025, CUBE, ARAS 4, FAKULTI PERUBATAN, UNIVERSITI MALAYA (05 Mar 2025 - 05 Mar 2025)
  14. FOUNDATIONS OF ASSESSMENT FOR HEALTH PROFESSIONALS 4 MAC 2025, CUBE, ARAS 4, FAKULTI PERUBATAN, UNIVERSITI MALAYA (04 Mar 2025 - 04 Mar 2025)
  15. ESSENTIAL OF TEACHING & LEARNING FOR HEALTH PROFESSIONALS 21 & 22 JANUARY 2025, CUBE, ARAS 4, FAKULTI PERUBATAN, UNIVERSITI MALAYA (21 Jan 2025 - 22 Jan 2025)